CISLINI JEFF (General Counsel) received a stock award from REVOLUTION MEDICINES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001610717-26-000080
Officer· General Counsel
Since Mar 2026
+47K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
47K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14.50K
Price / share
—
Trade value
—
% of position
30.9%
3/1/2026
46.98K→61.48K
Total
Net shares
+14.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +14.50K | — | — | 30.9% | 46.98K | 61.48K |
| Total | +14.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
32.50K shares
Shares
+32.50K
Strike price
102.02
Held after
32.50K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock32.50K shares | 3/1/2026 | A · Award | +32.50K | 102.02 | — | 32.50K |